Pradaxa Description



Boehringer Ingelheim
Full Prescribing Info
1 Capsule contains 86.48 mg, 126.83 mg or 172.95 mg of beta-alanine, N-[[2-[[[4(hexyloxy)carbonyl]amino]iminomethyl] phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester, methane-sulfonate, being the methane sulfonic acid salt (Corresponding to dabigatran etexilate base form 75 mg, 110 mg or 150 mg).
Excipients/Inactive Ingredients: Tartaric acid, acacia, hypromellose, dimethicone 350, talc, hydroxypropyl cellulose.
HPMC capsule shell: Carragenan, potassium chloride, titanium dioxide, Indigo Carmin (E132), hypromellose.
Printing ink: Shellac, N-butyl alcohol, isopropyl alcohol, Iron oxide black (E172), purified water, propylene glycol, ethanol, anhydrous potassium hydroxide, concentrated ammonia solution.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in